Historically, the diagnosis of glioblastomas relied on histological features, encompassing both IDH-mutated (10%) and IDH wild-type (90%) tumors, each manifesting markedly distinct biological characteristics and prognoses. The gene discussed is IDH1; the disease is glioblastoma.